Companies / Materials
SHW
Sherwin-Williams
Specialty Chemicals
Specialty ChemicalsAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health56
Growth32
Profitability58
Cash generation65
Balance sheet38
Dilution control88
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)7.9%Revenue growth (FY)2.1%Revenue CAGR (3y)2.1%Gross margin48.8%Operating margin—Net margin10.9%Free cash flow margin11.3%R&D / revenue—Stock comp / revenue0.5%Net debt / operating cash flow3.19xCurrent ratio0.87Diluted share count change-1.5%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $19.9B | $22.1B | $23.1B | $23.1B | $23.6B |
| Gross profit | $8.5B | $9.3B | $10.8B | $11.2B | $11.5B |
| Operating income | $3.1B | $3.4B | $4.2B | — | — |
| Net income | $1.9B | $2.0B | $2.4B | $2.7B | $2.6B |
| Operating cash flow | $2.2B | $1.9B | $3.5B | $3.2B | $3.5B |
| Capital expenditure | $372M | $644M | $888M | $1.1B | $798M |
| Free cash flow | $1.9B | $1.3B | $2.6B | $2.1B | $2.7B |
| Stock-based comp | $98M | $100M | $116M | $138M | $124M |
| Dividends | $587M | $618M | $624M | $723M | $790M |
| Cash | $166M | $199M | $277M | $210M | $207M |
| Total debt | $9.9B | $10.6B | $10.9B | $10.9B | $11.2B |
| Equity | $2.4B | $3.1B | $3.7B | $4.1B | $4.6B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.